Serum hyaluronate in primary biliary cirrhosis—A biochemical marker for progressive liver damage
Anders Nyberg, Anna Engström‐Làurent, Lars Lööf – 1 January 1988 – To evaluate serum hyaluronate as a marker for progressive liver injury in patients with primary biliary cirrhosis, a longitudinal study including 48 patients was conducted with a mean follow‐up time of 40 months. The patients were examined every 6 months with a standardized set of conventional liver function tests, and a liver biopsy was performed every year.